Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 421 · FY2023 70 · FY2024 0 — 3-yr total 491
Operates in Healthcare Services — Specialized medicine - private practice. Per the activity note to the FY2024 annual report, the company operates as a specialized fertility treatment and in vitro fertilization center.
| Line item | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|
| 11,097 | 13,163 | 13,606 | 14,730 | 24,303 | 25,483 | +14.9% | |
| Total COGS | 2,544 | 2,725 | 7,320 | 2,686 | 4,081 | 4,373 | +9.4% |
| Gross Profit | 8,553 | 10,438 | 6,287 | 12,044 | 20,222 | 21,110 | +16.2% |
| Gross Margin | 77.1% | 79.3% | 46.2% | 81.8% | 83.2% | 82.8% | |
| Other Operating Income | 0 | 0 | 0 | 50 | 18 | 8 | -60.0% |
| 5,727 | 7,768 | 2,329 | 8,675 | 11,875 | 11,384 | +12.1% | |
| EBITDA | 2,827 | 2,670 | 3,957 | 3,419 | 8,365 | 9,734 | +22.9% |
| EBITDA Margin | 25.5% | 20.3% | 29.1% | 23.2% | 34.4% | 38.2% | |
| Total D&A | 283 | 287 | 726 | 1,175 | 1,019 | 829 | +19.6% |
| EBIT / Operating Income | 2,544 | 2,383 | 3,232 | 2,244 | 7,346 | 8,905 | +23.2% |
| Total Interest Income | 0 | 0 | 0 | 1,611 | 0 | 463 | -46.4% |
| Total Interest Expense | 0 | 0 | 676 | 0 | 425 | 0 | -20.7% |
| 0 | 0 | 1,991 | 45 | 61 | 22 | nmf | |
| Profit Before Tax | 2,544 | 2,383 | 4,547 | 3,810 | 6,982 | 9,346 | +24.2% |
| Total Income Tax | 269 | 171 | 37 | 0 | 0 | 0 | -48.3% |
| Net Profit / (Loss) | 2,274 | 2,212 | 4,502 | 3,810 | 6,982 | 9,346 | +26.6% |
| Net Margin | 20.5% | 16.8% | 33.1% | 25.9% | 28.7% | 36.7% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →